PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $19,000 | -80.2% | 838 | -91.1% | 0.00% | 0.0% |
| Q3 2020 | $96,000 | +52.4% | 9,468 | +124.0% | 0.00% | -66.7% |
| Q2 2020 | $63,000 | +293.8% | 4,227 | +212.4% | 0.00% | +200.0% |
| Q1 2020 | $16,000 | -76.1% | 1,353 | -67.8% | 0.00% | -83.3% |
| Q4 2019 | $67,000 | +737.5% | 4,206 | +585.0% | 0.01% | +500.0% |
| Q2 2019 | $8,000 | – | 614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|